What is Exdensur? A new FDA-approved asthma biologic from GSK that only needs two doses a year for severe eosinophilic asthma ...

Sanofi and Regeneron receives Japanese marketing approval for Dupixent to treat bronchial asthma in children aged 6 to 11 years: Paris Wednesday, December 24, 2025, 11:00 Hrs [IST ...

Oral corticosteroids present significant long-term risks with uncertain evidence for improving asthma outcomes, according to data presented at the American College of Allergy, Asthma & Immunology ...

Dec 24 (Reuters) - Sanofi (SASY.PA) said on Wednesday it will buy U.S. biotech Dynavax Technologies (DVAX.O) for around $2.2 ...

Here are the top 5 AJMC.com articles and videos on allergy for 2025.

High airway TSLP asthma is linked to severe disease, type 2 inflammation, and airway remodelling. Learn more about how TSLP may guide targeted treatment.

ORLANDO — Children and adolescents with food allergy often experience substantial fear of negative social evaluation, ...

The Delhi High Court stays Kuldeep Singh Sengar's sentence pending appeal, after AIIMS reports outline multiple medical ...

Pittsburgh Steelers veteran Cam Heyward has seen plenty of change over the course of his long NFL career — but strong ...

"So, because of this, when you have a cough, cold, and difficulty in breathing, etc., then your regular treatment stops. Because of that, you have to wait for the chemotherapy. There is a break in ...

As winter intensifies, pediatric wards at Shaheed Suhrawardy Medical College Hospital in the capital are under severe strain due to a sharp rise in cold-related illnesses among children, hospital ...

Shares of Dynavax Technologies jumped sharply in premarket trading on Wednesday after the US vaccine maker agreed to be acquired by French pharmaceutical group Sanofi in an all-cash deal valued at ...